Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;38(1):9-14.
doi: 10.1002/hed.23842. Epub 2015 Jun 26.

Serum biomarkers for detection of head and neck squamous cell carcinoma

Wojciech K Mydlarz  1 , Patrick T Hennessey  1 , Hao Wang  2 , Andre Lopez Carvalho  3 , Joseph A Califano  1   4
Affiliations

Serum biomarkers for detection of head and neck squamous cell carcinoma

Wojciech K Mydlarz et al. Head Neck. 2016 Jan.

Abstract

Background: Detection of hypermethylated circulating tumor DNA has the potential to be a minimally invasive, low cost, and reproducible method for cancer detection.

Methods: We evaluated serum from 100 patients with known head and neck squamous cell carcinoma (HNSCC) and 50 healthy control patients for 3 previously described methylation targets, endothelin receptor type B (EDNRB), cyclin-dependent kinase inhibitor 2A (CDKN2A or p16), and deleted in colorectal carcinoma (DCC), using quantitative methylation specific polymerase chain reaction (qMSPCR).

Results: EDNRB hypermethylation was identified in the serum of 10% of the patients with HNSCC but in none of the control patients. DCC hypermethylation was detected in 2 serum samples from patients with cancer that also amplified EDNRB and one of these samples also had p16 hypermethylation. EDNRB hypermethylation was statistically significant by Fisher's exact test (p = .03) when comparing HNSCC to controls.

Conclusions: Serum EDNRB hypermethylation is a highly specific but not sensitive serum biomarker for HNSCC.

Keywords: epigenetics; head and neck cancer; head and neck squamous cell carcinoma (HNSCC); hypermethylation; screening.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: None of the authors of this manuscript have any relationships, financial or otherwise, or actual, potential, or perceived conflicts of interest to disclose.

Figures

Figure 1
Figure 1
EDNRB, DCC and p16 QMSP results in HNSCC and normal serum DNA.
See this image and copyright information in PMC

References

    1. Belinsky SA, Liechty KC, Gentry FD, et al. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res. 2006;66(6):3338–44. - PubMed
    1. Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 2000;60(21):5954–8. - PubMed
    1. Hoque MO, Begum S, Topaloglu O, et al. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res. 2004;64(15):5511–7. - PubMed
    1. El-Naggar AK, Mao L, Staerkel G, et al. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn. 2001;3(4):164–70. - PMC - PubMed
    1. Nunes DN, Kowalski LP, Simpson AJ. Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings. Oral Oncol. 2000;36(6):525–8. - PubMed

Publication types

MeSH terms

Substances